112 related articles for article (PubMed ID: 16753365)
1. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.
Nakanishi J; Wada Y; Matsumoto K; Azuma M; Kikuchi K; Ueda S
Cancer Immunol Immunother; 2007 Aug; 56(8):1173-82. PubMed ID: 17186290
[TBL] [Abstract][Full Text] [Related]
3. Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
Kondo T
Int J Urol; 2024 Feb; 31(2):133. PubMed ID: 37997623
[No Abstract] [Full Text] [Related]
4. Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma".
Urabe F; Tsuzuki S; Kimura T
Ann Surg Oncol; 2024 May; 31(5):3563-3564. PubMed ID: 38461193
[No Abstract] [Full Text] [Related]
5. Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma," by Urabe, Fumihik et al.
Milojevic B
Ann Surg Oncol; 2024 May; 31(5):3565-3566. PubMed ID: 38466487
[No Abstract] [Full Text] [Related]
6. Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.
Vaughn DJ; Bellmunt J; Fradet Y; Lee JL; Fong L; Vogelzang NJ; Climent MA; Petrylak DP; Choueiri TK; Necchi A; Gerritsen W; Gurney H; Quinn DI; Culine S; Sternberg CN; Mai Y; Li H; Perini RF; Bajorin DF; de Wit R
J Clin Oncol; 2018 Jun; 36(16):1579-1587. PubMed ID: 29590008
[TBL] [Abstract][Full Text] [Related]
7. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J; de Wit R; Vaughn DJ; Fradet Y; Lee JL; Fong L; Vogelzang NJ; Climent MA; Petrylak DP; Choueiri TK; Necchi A; Gerritsen W; Gurney H; Quinn DI; Culine S; Sternberg CN; Mai Y; Poehlein CH; Perini RF; Bajorin DF;
N Engl J Med; 2017 Mar; 376(11):1015-1026. PubMed ID: 28212060
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapies in Cancer.
Tariq MR; Ali SW; Fatima N; Jabeen A; Qazi AS; Hameed A; Safdar W
Cancer Treat Res; 2023; 185():59-77. PubMed ID: 37306904
[TBL] [Abstract][Full Text] [Related]
9. First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
Strauss J; Deville JL; Sznol M; Ravaud A; Maruzzo M; Pachynski RK; Gourdin TS; Maio M; Dirix L; Schlom J; Donahue RN; Tsai YT; Wang X; Vugmeyster Y; Beier F; Seebeck J; Schroeder A; Chennoufi S; Gulley JL
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37236636
[TBL] [Abstract][Full Text] [Related]
10. Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis.
Kaczmarek K; Lemiński A; Gołąb A; Słojewski M
Arch Med Sci; 2021; 17(3):603-612. PubMed ID: 34025829
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.
Yu LC; Chang CH; Huang CP; Huang CY; Hong JH; Tai TY; Weng HY; Lo CW; Tsai CY; Lee YK; Tsai YC; Hsueh TY; Chen YT; Chen IH; Chiang BJ; Tseng JS; Wu CC; Lin WY; Chien TM; Sheu ZL; Li CC; Ke HL; Li WM; Lee HY; Wu WJ; Yeh HC
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33261187
[TBL] [Abstract][Full Text] [Related]
12. The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery.
Tam AW; Liaw C; Li E; Katims AB; Say RK; Gul Z; Winoker JS; Martini A; Audenet F; Sfakianos JP
Can Urol Assoc J; 2021 May; 15(5):E248-E255. PubMed ID: 33119498
[TBL] [Abstract][Full Text] [Related]
13. Role of Multimodal Treatment in Urothelial Carcinoma Spinal Metastasis: 15 Patients' Experiences in a Single Center.
Wang T; Gao X; Zhang K; Yang J; Wu Z; Liu T; Jia Q; Xiao J
Cancer Manag Res; 2020; 12():9003-9012. PubMed ID: 33061595
[TBL] [Abstract][Full Text] [Related]
14. Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.
Apolo AB; Ellerton JA; Infante JR; Agrawal M; Gordon MS; Aljumaily R; Gourdin T; Dirix L; Lee KW; Taylor MH; Schöffski P; Wang D; Ravaud A; Manitz J; Pennock G; Ruisi M; Gulley JL; Patel MR
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037118
[TBL] [Abstract][Full Text] [Related]
15. Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001-2011.
Medunjanin D; Sonicki Z; Vena JE; Cvitkovic A; Robb SW
BMC Cancer; 2019 Oct; 19(1):950. PubMed ID: 31615453
[TBL] [Abstract][Full Text] [Related]
16. Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study.
Şefik E; Çelik S; Günlüsoy B; Basmacı İ; Yarımoğlu S; Bozkurt İH; Değirmenci T; Dinçel Ç
Turk J Urol; 2019 Dec; 45(Supp. 1):S49-S55. PubMed ID: 30978166
[TBL] [Abstract][Full Text] [Related]
17. 8-armed octopus: Evaluation of clinicopathologic prognostic factors of urothelial carcinoma of the upper urinary system.
Ekmekçi S; Küçük Ü; Dere Y; Çakır E; Sayar HC; Ergani B; Çakmak Ö; Bozkurt O; Yörükoğlu K
Turk J Med Sci; 2019 Feb; 49(1):153-161. PubMed ID: 30764592
[TBL] [Abstract][Full Text] [Related]
18. Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?
Goldberg H; Cheung DC; Chandrasekar T; Klaassen Z; Wallis CJD; Kulkarni GS; Sayyid R; Evans A; Masoomian M; Bapat B; van der Kwast T; Hamilton RJ; Zlotta A; Fleshner N
Can Urol Assoc J; 2019 Sep; 13(9):E292-E299. PubMed ID: 30763230
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy.
Rose TL; Chism DD; Alva AS; Deal AM; Maygarden SJ; Whang YE; Kardos J; Drier A; Basch E; Godley PA; Dunn MW; Kim WY; Milowsky MI
Br J Cancer; 2018 Oct; 119(7):801-807. PubMed ID: 30293995
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.
Tan P; Xie N; Liao H; Zou L; Xu H; Yang L; Liu L; Wei Q
Medicine (Baltimore); 2018 Sep; 97(37):e12300. PubMed ID: 30212968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
